Assessing the environmental impact of a drug for shrimp health
Environmental Assessment for Oxytetracycline Dihydrate Administered to Shrimp for Minor Use Minor Species
This study is looking at how a medication called oxytetracycline affects the environment when used to help keep shrimp healthy and prevent them from getting sick, so that shrimp farmers can safely use it to reduce shrimp deaths caused by bacteria.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Phibro Animal Health Corporation NIH-funded |
| Lab location | 1 site (Teaneck, United States) |
| Project ID | NIH-10885517 on NIH RePORTER |
What this research studies
This research focuses on evaluating the environmental effects of administering oxytetracycline to penaeid shrimp, which are important in aquaculture. The study aims to gain FDA approval for a medicated article that helps control mortality in shrimp caused by a specific bacterial infection. The methodology includes assessing the conditions of drug use, exposure levels, and potential risks associated with its application in shrimp farming. By understanding these factors, the research seeks to ensure the safe use of this medication in aquatic environments.
Who could benefit from this research
Good fit: Ideal candidates for this research are shrimp farmers and aquaculture operators who rely on penaeid shrimp for their livelihoods.
Not a fit: Patients who do not engage in shrimp farming or are not involved in aquaculture may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved health and survival rates for penaeid shrimp, benefiting aquaculture practices.
How similar studies have performed: While the specific application of oxytetracycline in shrimp is being assessed, similar environmental assessments for veterinary drugs in aquaculture have shown success in the past.
Where this research is happening
Teaneck, United States
- Phibro Animal Health Corporation — Teaneck, United States (Active)
Researchers
- Principal investigator: Parker, Sean — Phibro Animal Health Corporation
- Study coordinator: Parker, Sean
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.